Background: The Chinese patent drug Yinzhihuang granule (YZHG) is used to treat hepatitis B. This research is aimed at exploring the multicomponent synergistic mechanism of YZHG in the treatment of inflammation-cancer transformation of hepar and at providing new evidence and insights for its clinical application.
Methods: To retrieve the components and targets of Yinzhihuang granules. The differentially expressed genes (DEGs) of hepar inflammation-cancer transformation were obtained from TTD, PharmGKB, and GEO databases. Construct the compound-prediction target network and the key module network using Cytoscape 3.7.1.
Results: The results show that hepatitis B and hepatitis C shared a common target, MMP2. CDK1 and TOP2A may play an important role in the treatment with YZHG in hepatitis B inflammatory cancer transformation. KEGG pathway enrichment showed that key genes of modules 1, 2, and 4 were mainly enriched in the progesterone-mediated oocyte maturation signaling pathway and oocyte meiosis signaling pathway.
Conclusion: The multicomponent, multitarget, and multichannel pharmacological benefits of YZHG in the therapy of inflammation-cancer transition of hepar are directly demonstrated by network pharmacology, providing a scientific basis for its mechanism.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956385 | PMC |
| http://dx.doi.org/10.1155/2022/6213865 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hexavalent chromium exposure induces lung injury via activation of NLRP3 and AIM2 inflammasomes in rats.
Ecotoxicol Environ Saf
November 2024
Department of Scientific Research, Henan Medical College, Zhengzhou City, Henan Province 451191, China. Electronic address:
Article Synopsis
- * A study on SD rats revealed that Cr(VI) exposure led to increased lung damage, apoptosis in lung cells, and alterations in various blood and urine metal levels, which suggest significant biochemical changes.
- * After stopping Cr(VI) exposure, some damage showed improvement, indicating potential for recovery, but oxidative stress in lung tissues remained disrupted even after 14 days of cessation.
Network pharmacology and experimental verification: Unraveling Zhiwei Fuwei Pills's role and mechanism in angiogenesis of precancerous lesions of gastric cancer.
Hum Exp Toxicol
September 2024
Diagnosis and Treatment Center for Spleen and Stomach Diseases, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou, China.
Article Synopsis
- A study was conducted to investigate the effectiveness and mechanisms of Zhiwei Fuwei Pills (ZWFW), a traditional Chinese medicine, in treating precancerous lesions of gastric cancer (PLGC), which are crucial stages in the early development of gastric cancer.
- The researchers utilized various databases to identify active ingredients in ZWFW and their targets, then created protein-protein interaction networks and conducted pathway analysis to explore how ZWFW works against PLGC.
- Results indicated that ZWFW involves 258 active ingredients, 325 targets, and key signaling pathways like PI3K/Akt and HIF-1, suggesting its potential in preventing the progression of gastric cancer.
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer.
Chin Med
August 2024
School of Pharmacy, Lanzhou University, Lanzhou, 730000, China.
Danggui Buxue (DGBX) decoction is a classical prescription composed of Astragali Radix (AR) and Angelicae Sinensis Radix (ASR), used to enrich blood, and nourish Qi in Chinese medicine, with the potential to recover energy and stimulate metabolism. Chronic inflammation is a risk factor in the development of inflammatory bowel disease (IBD)-related colorectal cancer (CRC). More importantly, AR and ASR have anti-inflammatory and anti-cancer activities, as well as prefiguring a potential effect on inflammation-cancer transformation.
View Article and Find Full Text PDFHigh-throughput sequencing analysis of differential microRNA expression in the process of blocking the progression of chronic atrophic gastritis to gastric cancer by Xianglian Huazhuo formula.
J Tradit Chin Med
August 2024
Department of spleen and stomach diseases, First Affiliated Hospital of Hebei University of Traditional Chinese Medicine, Shijiazhuang 050000, China.
Article Synopsis
- The study investigates how the Xianglian Huazhuo formula (XLHZ) may prevent chronic atrophic gastritis (CAG) from progressing to gastric cancer (GC) using bioinformatics and laboratory analyses.
- Researchers used high-throughput sequencing to identify differentially expressed miRNAs and target genes, and applied various techniques to study XLHZ's effects on cell behavior in CAG cells.
- The findings suggest that XLHZ enhances E-cadherin expression while reducing factors that promote cell migration and proliferation, thereby potentially blocking the progression from CAG to GC.
Gambogenic acid induces apoptosis via upregulation of Noxa in oral squamous cell carcinoma.
Chin J Nat Med
July 2024
Department of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China; Laboratory of Inflammation and Molecular Pharmacology, School of Basic Medical Sciences & Biomedical Research Institute, Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmacy, Hubei University of Medicine, Shiyan 442000, China; Inflammation-Cancer Transformation and Wudang Chinese Medicine Research, Hubei Talent Introduction and Innovation Demonstration Base, Hubei University of Medicine, Shiyan 442000, China. Electronic address:
Gambogenic acid (GNA), a bioactive compound derived from the resin of Garcinia hanburyi, has demonstrated significant antitumor properties. However, its mechanisms of action in oral squamous cell carcinoma (OSCC) remain largely unclear. This study aimed to elucidate the apoptotic effects of GNA on OSCC cell lines CAL-27 and SCC-15.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!